🇺🇸 No aspirin in United States

11 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 23 April 2025 – 23 April 2026
• Total reports: 11

Most-reported reactions

1. Diarrhoea — 2 reports (18.18%)
2. Clostridium Difficile Infection — 1 report (9.09%)
3. Decreased Appetite — 1 report (9.09%)
4. Drug Ineffective — 1 report (9.09%)
5. Flushing — 1 report (9.09%)
6. Headache — 1 report (9.09%)
7. Hot Flush — 1 report (9.09%)
8. Impaired Quality Of Life — 1 report (9.09%)
9. Injection Site Pain — 1 report (9.09%)
10. Lower Respiratory Tract Infection — 1 report (9.09%)

Source database →

Frequently asked questions

Is No aspirin approved in United States?

No aspirin does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for No aspirin in United States?

Kyoto University, Graduate School of Medicine is the originator. The local marketing authorisation holder may differ — check the official source linked above.